Abstract
BackgroundAntitumor activity of natural killer (NK) cells can be enhanced by specific targeting with therapeutic antibodies that trigger antibody-dependent cell-mediated cytotoxicity (ADCC) or genetic engineering with chimeric antigen receptors (CARs)....
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have